Navigation Links
Sixty-One Percent of Newly Diagnosed Parkinson's Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
Date:8/19/2007

n dopamine agonist patient share first line. Patients will benefit from the introduction of new agents, including new formulations and line extensions within the dopamine agonist class. However, GlaxoSmithKline's Requip will face generic competition in 2008, so the overall market for dopamine agonists will begin to diminish, despite the launch of new agents in this class."

About Treatment Algorithm Insight Series

Decision Resources combines in-depth primary research with the most extensive claims-based longitudinal patient-level data from PharMetrics(R) to provide exceptional insight into physicians' prescribing trends and the factors that drive therapy product choice, from diagnosis through multiple courses of treatment, for a specific disease.

For each disease examined, Decision Resources' Treatment Algorithms Insight Series provides:

-- Summary of U.S. medical practice based on interviews with leading

experts in the field

-- Qualitative diagnosis/referral/treatment algorithm for the

United States

-- Drug usage by lines of therapy (1st, 2nd, 3rd line)

-- Discussion of key freeform combinations by lines of therapy

-- Product share (class and specific compound level) within each line of

therapy (1st, 2nd, 3rd line)

-- Progression of therapy from key 1st line products

-- Pathway to key therapies from previous therapies

-- Qualitative analysis of 2-year forecast incorporating upcoming

launches, changes in reimbursement, etc.

About Decision Resources

Decision Resources, Inc., (http://www.DecisionResources.com) is a world leader in healthcare market research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets.

All company, brand, or product names contained in this document may be trademarks or registered
'/>"/>

SOURCE Decision Resources

Copyright©2007 PR Newswire.

Page: 1 2 3

Related medicine technology :

1. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
2. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
3. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
4. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
5. Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free Survival by 45 Percent in Patients With Intermediate-Risk Kidney Cancer
6. Data Published in The Lancet Show Gardasil was 100 Percent Effective in Preventing High-Grade Vulvar and Vaginal Lesions Caused by HPV Types 16 and 18
7. Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate Dependency Treatment Are Mothers
8. Eighty-one Percent of U.S. Adults say that Birth Control Pills and Procedures Should Be Covered by Health Insurance
9. Cervarix, GSK Cervical Cancer Candidate Vaccine, Demonstrates 100 Percent Protection Against Precancerous Lesions Caused By Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than Five Years
10. Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Growth of Both Hormone-Dependent and Hormone-Independent Prostate Cancer by Up to 94 Percent in Preclinical Studies
11. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., CANOGAPARK,Calif.,Nov.25/PRNewswire/--PraxisE...ntheAmericanAcademyofFamilyPhysicians,(AAFP)Family...eyforimprovingmedicalquality,healthmaintenance,and...islation.Praxisalsoranked#1amongdoctorsindicatingt...Finally,Praxisalsorankednumberoneinthecountryinpro...
(Date:11/25/2009)..., PRINCETON,N.J.,Nov.25/PRNewswire-FirstCall/--...aceuticalcompanycommittedtodiscovering,developinga...reportedfinancialresultsforthefiscalyearendedSepte...illionincash,cashequivalentsandshortterminvestment...RG7128 ,, Phase2bTrial ,, InlateNovembe...
(Date:11/25/2009)..., BRIDGEWATER,N.J.,Nov.25/PRNewswire/--TheFDAgr...ine)tablets,anon-nucleosidereversetranscriptaseinh...ndicatedforuseintreatment-experiencedadultswhoaree...nttoanNNRTIandotherantiretroviral(ARV)agents.Thetr...studiesknownasDUET-1andDUET-2.INTELENCEiscurrently...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4VA Secretary Addresses 65th Annual AMVETS Convention 54464 1VA Secretary Addresses 65th Annual AMVETS Convention 54464 2VA Secretary Addresses 65th Annual AMVETS Convention 54464 3VA Secretary Addresses 65th Annual AMVETS Convention 54464 4Bone Safety 101 54462 1Bone Safety 101 54462 1
(Date:11/25/2009)...SANGELES,Nov.25/PRNewswire-USNewswire/--TheBlackAI...etermineexecutiveleadershipfor2010. ,, ThenewBo...altiesinpublicpolicy,law,finance,governmenthealthp...oardalsocomesfromawiderangeofpersonalbackgroundsin...livingwithHIVthemselves,andrepresentingmultipleage...
(Date:11/25/2009)...ers have found evidence of a statistically signifi...g patients whose estrogen receptor (ER)-positive t...ha; at serine-118 (ER-alpha S118-P), according to ... in the Journal of the National Cancer Institute ...esistant to tamoxifen. Preclinical studies have sh...
(Date:11/25/2009)... already used to fight rheumatoid arthritis, could... , WEDNESDAY, Nov. 25 (HealthDay News) -- A ... and rheumatoid arthritis now also shows some prom...1 diabetes. , The drug, rituximab (Rituxan), he...ulin, even though the disease had destroyed some o...
(Date:11/25/2009)...sitive note, CDC sees few signs of trouble with th...(HealthDay News) -- The ongoing H1N1 swine flu pan...neumonias among younger patients, a U.S. health of...ease in serious pneumococcal infections around the...onal Center for Immunization and Respiratory Disea...
(Date:11/25/2009)...E, Mass. -- A cancer vaccine carried into the body...nt is the first to successfully eliminate tumors i...nal Science Translational Medicine . , The new ...sts at Harvard University, uses plastic disks impr... under the skin to reprogram the mammalian immune ...
Breaking Medicine News(10 mins):Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
...help them form connections with others, such as br...a family of their own.// Even teens who acknowled...dvantages in attaining motherhood early in life. ...onnect with others in life besides motherhood," sa...
...on cancer prevention was launched in China on 7th ...eath in China, according the Ministry of Health de...the deaths. According to a study, environmental a...the cancer patients by 5 years. Mao Qun’an, a...
... from red algae to be a potent inhibitor of Human ...and genital warts//. The study has been published...pound carrageenan, a commercial thickening agent, ...ive way to block cervical cancer than HPV vaccine,...
...dian-origin mother and her two children last year ...she was treated for mental illness. Navjeet S...erself and her two children, Simran (5) and Aman R...t into the deaths by the West London Health Trust ...
...he symptoms of MS, say researchers, who have zeroe...he development of novel strategies// to treat this... cure is not yet in place. The study has in... Multiple Sclerosis. Italian and German scientist...
...ur-year-old conjoined twin girls, surgeons in the ...are working// to separate their liver. The op...to try to separate twins who share a kidney. Kendr...ns will each have one leg with Kendra getting the ...
Other Medicine News:Health News:Teens and Pregnancy 2Health News:Teens and Pregnancy 3Health News:New Cancer-Blocking Algae Found 2
1.0 mm Micro System
Grafton DBM Matrix PLF
Optium DBM Gel, TGEL05
...w generation Endoalpha is a centralized O.R. contr...urse by giving them better control, better informa...protection against obsolescence, as future enhance... than the purchase of an entirely new system. Endo...
Medicine Products: